1. Home
  2. BGNE
  3. BGNE News

Latest BeiGene Ltd. (BGNE) News on December 18, 2024

BGNE

MT Newswires

5 days ago

Sector Update: Health Care

BGNE

MT Newswires

6 days ago

BeiGene Enters Global Licensing Agreement with CSPC Zhongqi for Experimental Cancer Therapy

BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor
BGNE

Business Wire

6 days ago

BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor

BGNE

MT Newswires

6 days ago

Beigene Insider Sold Shares Worth $7,805,106, According to a Recent SEC Filing

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
BGNE

Business Wire

9 days ago

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets

BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL
BGNE

Business Wire

15 days ago

BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL

BeiGene Gains Overweight Rating from Morgan Stanley with $300 Price Target
BGNE

GuruFocus.com

15 days ago

BeiGene Gains Overweight Rating from Morgan Stanley with $300 Price Target

Why Is BeiGene, Ltd. (BGNE) Among the Best High Growth Healthcare Stocks to Invest In Now?
BGNE

Insider Monkey

16 days ago

Why Is BeiGene, Ltd. (BGNE) Among the Best High Growth Healthcare Stocks to Invest In Now?

BeiGene to Host Investor Webcast Highlighting Key Data from ASH and the San Antonio Breast Cancer Symposium on December 16, 2024
BGNE

Business Wire

17 days ago

BeiGene to Host Investor Webcast Highlighting Key Data from ASH and the San Antonio Breast Cancer Symposium on December 16, 2024

BGNE

MT Newswires

17 days ago

BeiGene Insider Sold Shares Worth $9,190,570, According to a Recent SEC Filing

BeiGene’s PD-1 drug approved in EU for first-line oesophageal cancer treatment
BGNE

Pharmaceutical Technology

21 days ago

BeiGene’s PD-1 drug approved in EU for first-line oesophageal cancer treatment

Why Is BeiGene Stock Trading Higher On Wednesday?
BGNE

Benzinga

21 days ago

Why Is BeiGene Stock Trading Higher On Wednesday?

BGNE

MT Newswires

21 days ago

BeiGene's Tevimbra Gets Approval From European Commission as Treatment for Cancer Patients

European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer
BGNE

Business Wire

22 days ago

European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer

BeiGene to Present at Upcoming Investor Conferences
BGNE

Business Wire

23 days ago

BeiGene to Present at Upcoming Investor Conferences

High Growth Tech Stocks to Watch in November 2024
BGNE

Simply Wall St.

23 days ago

High Growth Tech Stocks to Watch in November 2024

Labcorp CFO Glenn Eisenberg Announces Plans to Retire
BGNE

PR Newswire

a month ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA
BGNE

Business Wire

a month ago

BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA

BeiGene, Ltd. (BGNE): Among 12 High Growth Large Cap Stocks to Buy Now
BGNE

Insider Monkey

a month ago

BeiGene, Ltd. (BGNE): Among 12 High Growth Large Cap Stocks to Buy Now

Halozyme bids for Evotec; BeiGene gets a new name
BGNE

BioPharma Dive

a month ago

Halozyme bids for Evotec; BeiGene gets a new name

BGNE

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Pre-Bell Thursday

BGNE

MT Newswires

a month ago

BeiGene to Rename as BeOne Medicines

BeiGene Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
BGNE

Simply Wall St.

a month ago

BeiGene Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
BGNE

Business Wire

a month ago

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight
BGNE

GuruFocus.com

a month ago

Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight

BGNE

MT Newswires

a month ago

BeiGene Swings to Q3 Net Loss, Revenue Rises

BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
BGNE

Business Wire

a month ago

BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates

BeiGene to Present at the Jefferies London Healthcare Conference
BGNE

Business Wire

a month ago

BeiGene to Present at the Jefferies London Healthcare Conference

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BGNE

Business Wire

a month ago

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

BeiGene Mourns Death of Beloved Board Member Donald Glazer
BGNE

Business Wire

2 months ago

BeiGene Mourns Death of Beloved Board Member Donald Glazer

High Growth Tech Stocks to Watch in October 2024
BGNE

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in October 2024

BGNE

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

BGNE

MT Newswires

2 months ago

Top Midday Gainers

BGNE

MT Newswires

2 months ago

BeiGene's Stomach, Esophageal Cancer Drug Receives Positive European Committee Opinions

BGNE

MT Newswires

2 months ago

Nomura Raises Price Target on BeiGene to $293.78 From $266, Keeps Buy Rating

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
BGNE

Business Wire

2 months ago

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma

Recent 7.2% pullback isn't enough to hurt long-term BeiGene (NASDAQ:BGNE) shareholders, they're still up 60% over 5 years
BGNE

Simply Wall St.

2 months ago

Recent 7.2% pullback isn't enough to hurt long-term BeiGene (NASDAQ:BGNE) shareholders, they're still up 60% over 5 years

BeiGene Highlights Waldenström’s Macroglobulinemia Innovation at IWWM 2024
BGNE

Business Wire

2 months ago

BeiGene Highlights Waldenström’s Macroglobulinemia Innovation at IWWM 2024

BGNE

MT Newswires

2 months ago

Beigene Insider Sold Shares Worth $3,756,092, According to a Recent SEC Filing

Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3
BGNE

Insider Monkey

2 months ago

Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3

BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
BGNE

Zacks

2 months ago

BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?

3 Stocks That May Be Trading Below Intrinsic Value By Up To 48.2%
BGNE

Simply Wall St.

3 months ago

3 Stocks That May Be Trading Below Intrinsic Value By Up To 48.2%

BGNE

MT Newswires

3 months ago

BeiGene Shares Climb Pre-Bell After FDA Gives Favorable Opinion on Class of Cancer Treatments

BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers
BGNE

Business Wire

3 months ago

BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers

Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
BGNE

Business Wire

3 months ago

Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
BGNE

Benzinga

3 months ago

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients

High Growth Tech Stocks To Watch In September 2024
BGNE

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In September 2024

BGNE

MT Newswires

3 months ago

JMP Securities Initiates BeiGene at Outperform With $288 Price Target

BeiGene’s TEVIMBRA gains approval for OSCC in Israel
BGNE

Pharmaceutical Technology

3 months ago

BeiGene’s TEVIMBRA gains approval for OSCC in Israel

BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy
BGNE

Business Wire

3 months ago

BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy

BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk
BGNE

PR Newswire

3 months ago

BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk

SK hynix And 2 More Stocks Estimated To Be Trading Below Fair Value
BGNE

Simply Wall St.

3 months ago

SK hynix And 2 More Stocks Estimated To Be Trading Below Fair Value

BeiGene Announces Updates to Commercial Leadership Team
BGNE

Business Wire

3 months ago

BeiGene Announces Updates to Commercial Leadership Team

BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024
BGNE

Business Wire

3 months ago

BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024

Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?
BGNE

Zacks

4 months ago

Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?

3 US Stocks That Could Be Trading At A Discount
BGNE

Simply Wall St.

4 months ago

3 US Stocks That Could Be Trading At A Discount

BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
BGNE

Business Wire

4 months ago

BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

FDA grants fast track status to BeiGene’s BGB-16673 for CLL/SLL
BGNE

Pharmaceutical Technology

4 months ago

FDA grants fast track status to BeiGene’s BGB-16673 for CLL/SLL

BeiGene, Ltd. (BGNE) Just Flashed Golden Cross Signal: Do You Buy?
BGNE

Zacks

4 months ago

BeiGene, Ltd. (BGNE) Just Flashed Golden Cross Signal: Do You Buy?

BGNE

MT Newswires

4 months ago

Sector Update: Health Care Stocks Higher Pre-Bell Monday

BGNE

MT Newswires

4 months ago

Sector Update: Health Care

BGNE

MT Newswires

4 months ago

BeiGene Says BGB-16673 Gets FDA Fast Track Status for Lymphocytic Leukemia, Lymphoma

BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
BGNE

Business Wire

4 months ago

BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL

Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
BGNE

Benzinga

4 months ago

Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer

High Growth Tech Stocks To Watch In August 2024
BGNE

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In August 2024

3 US Stocks That May Be Undervalued According To Estimates
BGNE

Simply Wall St.

4 months ago

3 US Stocks That May Be Undervalued According To Estimates

Wall Street Analysts See a 40.85% Upside in BeiGene (BGNE): Can the Stock Really Move This High?
BGNE

Zacks

4 months ago

Wall Street Analysts See a 40.85% Upside in BeiGene (BGNE): Can the Stock Really Move This High?

BeiGene Second Quarter 2024 Earnings: Beats Expectations
BGNE

Simply Wall St.

4 months ago

BeiGene Second Quarter 2024 Earnings: Beats Expectations

Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)
BGNE

GuruFocus.com

4 months ago

Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)

BGNE

MT Newswires

4 months ago

BeiGene' Q2 Net Loss Narrows, Revenue Rises; Shares Gain

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
BGNE

Business Wire

4 months ago

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

NICE recommends BeiGene’s MZL tablet for NHS use
BGNE

Pharmaceutical Technology

5 months ago

NICE recommends BeiGene’s MZL tablet for NHS use

BeiGene opens biologics facility in New Jersey, US
BGNE

Pharmaceutical Technology

5 months ago

BeiGene opens biologics facility in New Jersey, US

BGNE

MT Newswires

5 months ago

BeiGene Opens Flagship US Biologics Manufacturing Facility in New Jersey

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
BGNE

Business Wire

5 months ago

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

BGNE

MT Newswires

5 months ago

BeiGene Names Aaron Rosenberg CFO

BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
BGNE

Business Wire

5 months ago

BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer

BGNE

MT Newswires

5 months ago

Nomura Adjusts BeiGene Price Target to $266 From $248.41, Maintains Buy Rating

When Will BeiGene, Ltd. (NASDAQ:BGNE) Become Profitable?
BGNE

Simply Wall St.

5 months ago

When Will BeiGene, Ltd. (NASDAQ:BGNE) Become Profitable?

Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)
BGNE

GuruFocus.com

6 months ago

Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)

BGNE

MT Newswires

6 months ago

Beigene Insider Sold Shares Worth $445,070, According to a Recent SEC Filing

Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains?
BGNE

Zacks

6 months ago

Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains?

Travere (TVTX) Stock Jumps 5.2%: Will It Continue to Soar?
BGNE

Zacks

6 months ago

Travere (TVTX) Stock Jumps 5.2%: Will It Continue to Soar?

Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)
BGNE

GuruFocus.com

6 months ago

Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)

BGNE

MT Newswires

6 months ago

Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing

BGNE

MT Newswires

6 months ago

BeiGene Says New Phase 3 Brukinsa Data Show 'Promising' Efficacy in Leukemia, Lymphoma

BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024
BGNE

Business Wire

6 months ago

BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024

BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region
BGNE

Business Wire

6 months ago

BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region

BeiGene, Ltd. (NASDAQ:BGNE) Shares Could Be 47% Below Their Intrinsic Value Estimate
BGNE

Simply Wall St.

6 months ago

BeiGene, Ltd. (NASDAQ:BGNE) Shares Could Be 47% Below Their Intrinsic Value Estimate

Italian energy company targets Britain for fleet of 20 mini-nukes
BGNE

The Telegraph

6 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
BGNE

Motley Fool

6 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North
BGNE

AFP

6 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
BGNE

Simply Wall St.

6 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations
BGNE

Simply Wall St.

6 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
BGNE

Simply Wall St.

6 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
BGNE

Simply Wall St.

6 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled
BGNE

Motley Fool

6 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
BGNE

Business Wire

6 months ago

BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

BGNE

MT Newswires

7 months ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study

BGNE

MT Newswires

7 months ago

BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments

Share on Social Networks: